These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16126989)

  • 1. New facet of antiphospholipid antibodies.
    Valesini G; Alessandri C
    Ann N Y Acad Sci; 2005 Jun; 1051():487-97. PubMed ID: 16126989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
    Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New autoantigens in the antiphospholipid syndrome.
    Alessandri C; Conti F; Pendolino M; Mancini R; Valesini G
    Autoimmun Rev; 2011 Aug; 10(10):609-16. PubMed ID: 21545849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfatides: targets for anti-phospholipid antibodies.
    Merten M; Motamedy S; Ramamurthy S; Arnett FC; Thiagarajan P
    Circulation; 2003 Oct; 108(17):2082-7. PubMed ID: 14530197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
    Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
    Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beta-2-glycoprotein I and antiphospholipid antibodies.
    Shoenfeld Y; Meroni PL
    Clin Exp Rheumatol; 1992; 10(2):205-9. PubMed ID: 1505119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
    J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells.
    Galve-de Rochemonteix B; Kobayashi T; Rosnoblet C; Lindsay M; Parton RG; Reber G; de Maistre E; Wahl D; Kruithof EK; Gruenberg J; de Moerloose P
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):563-74. PubMed ID: 10669657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis.
    Alessandri C; Sorice M; Bombardieri M; Conigliaro P; Longo A; Garofalo T; Manganelli V; Conti F; Esposti MD; Valesini G
    Arthritis Res Ther; 2006; 8(6):R180. PubMed ID: 17150088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome: 30 years and our contribution.
    Koike T
    Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
    Yasuda S; Bohgaki M; Atsumi T; Koike T
    Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.